About Scipher Medicine
Scipher Medicine is a private company based in Waltham, Massachusetts. It has reported $122,977,311 raised in seven offerings on Form D since November 2015. Its chief executive is Reginald Seeto.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 2, 2024 | Jul 30, 2024 | $5,849,013fully sold | 1 | $5.8M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 12, 2021 | Mar 26, 2021amended Mar 31, 2021 | $81,999,988fully sold | 12 | $6.8M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 8, 2019 | May 20, 2019amended Oct 10, 2019 | $24,999,873fully sold | 15 | $1.6M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 3, 2018 | Aug 17, 2018 | $8,533,437fully sold | 11 | $775K | EquityRule 506(b) | Form D ↗ |
| May 9, 2018 | May 24, 2018 | $795,000of $5.3M target | 5 | $159K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 20, 2016 | Nov 7, 2016 | $575,000of $1.0M target | 12 | $47,917 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 5, 2015 | Nov 30, 2015 | $225,000of $600K target | 3 | $75,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, seven offerings | $122,977,311 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Scipher Medicine's Form D filed Jul 30, 2024.
Earlier filings also listed Michael Rubin (director, last listed Mar 2021), Jeffrey Sachs (secretary, last listed Mar 2021), Alif Saleh (executive officer and director, last listed Mar 2021), Albert Laszlo Barabasi (director, last listed Mar 2021), Byron Kalogerou (executive officer, last listed Oct 2019), Peter Ruppert (director, last listed Nov 2016), Marcell Veidner (president and director, last listed Nov 2015) and Albert Barabsi (director, last listed Nov 2015).